Rick Doblin
Impact in
- Clinical Psychology top 0.2%
- Psychedelics and Drug Studies
- Posttraumatic Stress Disorder Research
- Toxicology top 0.1%
- Forensic Toxicology and Drug Analysis
Papers in
-
- Psychedelics and Drug Studies 40
- Pharmacology 25
- Cannabis and Cannabinoid Research 23
- Treatment of Major Depression 5
- Co-authors
- Michael C. Mithoefer (21 shared papers)Lisa Jerome (16 shared papers)Berra Yazar‐Klosinski (18 shared papers)Ann T. Mithoefer (6 shared papers)Mark T. Wagner (5 shared papers)Amy Emerson (17 shared papers)Yvonne Anne Michel (2 shared papers)Dominique H. Holstein (1 shared paper)
- Journals
- Journal of Psychopharmacology (6 papers)Journal of Psychoactive Drugs (5 papers)PLoS ONE (3 papers)Nature Medicine (2 papers)Journal of Humanistic Psychology (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Rick Doblin
44 papers receiving 4.0k citations
Rick Doblin's Hit Papers
Peers
Comparison fields: 5 of 101
- Clinical Psychology 3.5k
- Toxicology 546
- Biological Psychiatry 179
- Cellular and Molecular Neuroscience 1.2k
- Pharmacology 905
Countries citing papers authored by Rick Doblin
This map shows the geographic impact of Rick Doblin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick Doblin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick Doblin more than expected).
Fields of papers citing papers by Rick Doblin
This network shows the impact of papers produced by Rick Doblin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick Doblin. The network helps show where Rick Doblin may publish in the future.
Co-authors
The 25 scholars most cited alongside Rick Doblin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study Hit paper breakdown → | 2021 | 669 |
| 2 | Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases Hit paper breakdown → | 2014 | 561 |
| 3 | The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study Hit paper breakdown → | 2010 | 498 |
| 4 | 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial Hit paper breakdown → | 2018 | 311 |
| 5 | 2012 | 303 | |
| 6 | MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial Hit paper breakdown → | 2023 | 264 |
| 7 | 2018 | 171 | |
| 8 | 2008 | 147 | |
| 9 | 2017 | 123 | |
| 10 | 2019 | 120 | |
| 11 | 2020 | 104 | |
| 12 | 1991 | 94 | |
| 13 | 2002 | 81 | |
| 14 | 2021 | 76 | |
| 15 | 2020 | 56 | |
| 16 | 2023 | 56 | |
| 17 | 2022 | 50 | |
| 18 | 2018 | 49 | |
| 19 | 2021 | 48 | |
| 20 | 2022 | 47 |
About Rick Doblin
Rick Doblin is a scholar working on Clinical Psychology, Pharmacology, Toxicology, Cellular and Molecular Neuroscience and Biological Psychiatry, having authored 45 papers that have together received 4.2k indexed citations. Recurring topics across this work include Psychedelics and Drug Studies (40 papers), Cannabis and Cannabinoid Research (23 papers), Forensic Toxicology and Drug Analysis (6 papers), Neurotransmitter Receptor Influence on Behavior (5 papers), Treatment of Major Depression (5 papers), Memory and Neural Mechanisms (4 papers), Tryptophan and brain disorders (3 papers) and Natural Compound Pharmacology Studies (2 papers). The work is most often cited by research in Clinical Psychology (3.5k citations), Toxicology (546 citations), Biological Psychiatry (179 citations), Cellular and Molecular Neuroscience (1.2k citations) and Pharmacology (905 citations). Rick Doblin has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Michael C. Mithoefer, Lisa Jerome, Berra Yazar‐Klosinski, Ann T. Mithoefer, Mark T. Wagner, Amy Emerson, Yvonne Anne Michel, Dominique H. Holstein, Peter Gasser and Rudolf Brenneisen. Their work appears in journals such as Journal of Psychopharmacology, Journal of Psychoactive Drugs, PLoS ONE, Nature Medicine and Journal of Humanistic Psychology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.